NIH Strategies-for-Overcoming-Barriers-to-PROs.pdf

8/20/2019 NIH Strategies-for-Overcoming-Barriers-to-PROs.pdf

1/19

"

!"#$"%!"#$ &'( )*#(+',"-! ./(("#($ 0' !"#

!"#$%"%&'(')*& *, -(')%&'!

!"#$%&"'!"#$%&'( *'+(",'(

#$ %&' '()*+, -).( /01+(21 3(1().4, -5**)65.)+5.0 7)+8($+ 3(95.+(:

;.)48( ?54@*().A 7,B"C D($E)28$ FG H8.85I1@0A HBJC F)2(1 '($.0 =8**8KA HBLC M).($ /+)2)$A H/"C

%.


2/19

J

!"#$% '( )'*+%*+,

7+8$(#9)8/(+ ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: ;

8$.8%?/%& :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: @ B(N8$( `5)*1 )$: ^a9(4+)+85$1 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG O ^1+)6*81, /+)$:).: ;9(.)+8$K 7.54(:.8KK(.1 N5. /9(48N84 &$+(.I($+85$1 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG V ^$K)K( /($85. 7,01848)$ -,)2985$1 GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG W

4.8/%+8 =.$$/%$& .+# >8$.8%?/%& ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: A

"#B/+/&8$.8/C% =.$$/%$& .+# >8$.8%?/%& ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: D H8118$K B)+) GGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGG "U

6/&)9&&/(+ ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: EF

G%'%$%+)%& :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: EH


3/19

L

-*+.'/01+2'*

#1 ,()*+, 101+(21 1,8N+ +5Q).: 4*8$84)* 9.)4+84( +,)+ 81 25.( 9)+8($+]4($+(.(:A +,( I584( 5N

+,( 9)+8($+ 81 8$4.()18$K*0 ,().: +,.5


4/19

O

)$2*212"* 3"..2%., "*/ 4+."+%52%,

&$ 251+ 9


5/19

T

8,+"#$2,; 4+"*/"./ '.?($'@

&$+(K.)+8$K 73; :)+) 8$+5 4*8$84)* Q5.@N*5Q :(9($:1 5$ +,( 4*8$84)* 14($).85G R5. 4*8$848)$1

)$: +,(8. 9)+8($+1A 8$+.5:


6/19

\

R8K,( 1


7/19

V

9)+8($+]9.5I8:(. 4522


8/19

W

8*5"5% 4%*2'. =;B,212"* );"C:2'*,

7,01848)$ 4,)2985$1 Q,5 I)*


9/19

[

>,(.( 81 )*15 ) 9(.I)18I( 6(*8(N +,)+ 8** 9)+8($+1 1+.


10/19

"U

#::.(118$K 811


11/19

""

9)+8($+1G >,(1( N)4+5.1 $((: $5+ 4529.5281( +,( b


12/19

"J

F%(%.%*1%,

"G /9(8K,+ FA D).($:1( /HG RB# K


13/19

"L

""G #6(.$(+,0 #7A '(.$:5$ F^ J$:A =,((*(. F?A (+ )*G R()1868*8+0 )$: )44(9+)68*8+0 +5

9)+8($+1 5N ) *5$K8+


14/19

"O

JJG B(1,9)$:( #BA /(N@5 F#A F(NN( BDA (+ )*G >,( )11548)+85$ 6(+Q(($ 4,.5$84 :81()1( 6


15/19

"T

LJG B5$)*:15$ H/G >)@8$K 1+54@ 5N ,()*+,].(*)+(: b


16/19

"\

+.8)*G F -*8$ ;$45* JU""CJ[Z"UJ[d"ULTG 7H&BZ J"JWJTOW 7H-&BZ 7H-LU\WUTLG :58Z

"UG"JUUYF-;GJU"UGLUGL[U[G

OLG -(**) BA 38*(0 =A /+5$( #A (+ )*G >,( 7)+8($+]3(95.+(: ;A =8**8K F'A -.)$( 'HA (+ )*G 35


17/19

"V

TJG D)14, ^A >5.:) 7A #:)21 MG /+)$:).:1 N5. 9)+8($+].(95.+(: 5,( 7)+8($+ 3(95.+(:

;


18/19

"W

\LG D)14, ^A &)15$51 #A D).e #A (+ )*G ?5$K]+(.2 +5a848+0 25$8+5.8$K I8) (*(4+.5$84 9)+8($+]

.(95.+(: 5,( 28118$K I584( 5N 9)+8($+1 8$ :.%(+9.82).0 4).( 9.)4+84(1Z 958$+ 5N 4).( :)+) 45**(4+85$ 5$ ,095K*04(28) )$: 5I(.]+,(]

45


19/19

"[

NIH Strategies-for-Overcoming-Barriers-to-PROs.pdf

Documents

Transcript of NIH Strategies-for-Overcoming-Barriers-to-PROs.pdf